SEC Form 4 · accession 0001209191-17-002816
Lineage Cell Therapeutics, Inc. · LCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Corp /ny Greenbelt
Other
Period of report
Jan 3, 2017
Accepted (ET)
Jan 6, 2017 · 9:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000876343
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, no par valueF1 | Jan 3, 2017 | J | 238,459 | — | D | 1,143,346 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Distribution to a shareholder in partial redemption of their shares of Greenbelt Corp. None of Mr. Kingley's shares in Greenbelt Corp. have been redeemed.
Remarks
Greenbelt Corp. is an affiliate of Alfred D. Kingsley, a director of BioTime, Inc.